Rutaecarpine-inspired scaffold-hopping strategy and Ullmann cross-coupling based synthetic approach: Identification of pyridopyrimidinone-indole based novel anticancer chemotypes

被引:1
作者
Yadav, Mukul [1 ]
Roy, Nibedita [1 ]
Mandal, Kartik [2 ]
Nagpure, Mithilesh [1 ]
Guchhait, Sankar K. [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res NIPER, Dept Med Chem, Mohali 160062, Punjab, India
[2] Pune Univ, Natl Ctr Cell Sci, NCCS Complex,Campus Ganeshkhind, Pune 411007, India
关键词
DRUG DISCOVERY; STRUCTURAL SIMPLIFICATION; BIOLOGICAL EVALUATION; SCREENING LIBRARIES; NATURAL-PRODUCTS; INHIBITORS; POTENT; SUPPRESSION; DERIVATIVES; EVODIAMINE;
D O I
10.1016/j.bmc.2024.117799
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Natural products as starting templates have shown historically major contribution to development of drugs. Inspired by the structure-function of an anticancer natural alkaloid Rutaecarpine, the Scaffold-hopped Acyclic Analogues of Rutaecarpine (SAAR) with 'N'-atom switch (1 degrees-hop) degrees-hop) and ring-opening (2 degrees-hop) degrees-hop) were investigated. A new synthetic route was developed for an effective access to the analogues, i.e. 2-indolyl-pyrido[1,2-a]pyrimidinones, a ]pyrimidinones, which involved preparation of N-Boc- N '- phthaloyltryptamine/mexamine-bromides and pyridopyrmidinon-2-yl triflate, a nickel/palladium-catalysed Ullmann cross-coupling of these bromides and triflate, deprotection of phthalimide followed by N-aroylation, and Boc-deprotection. Fourteen novel SAAR-compounds were prepared, and they showed characteristic antiproliferative activity against various cancer cells. Three most active compounds (11a, 11a , 11b, , and 11c) ) exhibited good antiproliferative activity, IC50 50 7.7-15.8 mu M against human breast adenocarcinoma cells (MCF-7), lung cancer cells (A549), and colon cancer cells (HCT-116). The antiproliferative property was also observed in the colony formation assay. The SAAR compound 11b was found to have superior potency than original natural product Rutaecarpine and an anticancer drug 5-FU in antiproliferative activities with relatively lower cytotoxicity towards normal breast epithelial cells (MCF10A) and significantly higher inhibitory effect on cancer cells' migration. The compound 11b was found to possess favourable in silico physicochemical characteristics (lipophilicity-MLOGP, TPSA, and water solubility-ESOL, and others), bioavailability score, and pharmacokinetic properties (GI absorption, BBB non-permeant, P-gp, and CYP2D6). Interestingly, the compound 11b did not show any medicinal chemistry structural alert of PAINS and Brenk filter. The study represents for the first time the successful discovery of new potent anticancer chemotypes using Rutaecarpine natural alkaloid as starting template and reaffirms the significance of natural product-inspired scaffold-hopping technique in drug discovery research.
引用
收藏
页数:14
相关论文
共 59 条
  • [1] Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance
    Abouelhassan, Yasmeen
    Garrison, Aaron T.
    Yang, Hongfen
    Chavez-Riveros, Alejandra
    Burch, Gena M.
    Huigens, Robert W., III
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (17) : 7618 - 7642
  • [2] Molecular medicinal insights into scaffold hopping-based drug discovery success
    Acharya, Ayan
    Yadav, Mukul
    Nagpure, Mithilesh
    Kumaresan, Sanathanalaxmi
    Guchhait, Sankar K.
    [J]. DRUG DISCOVERY TODAY, 2024, 29 (01)
  • [3] Multimetallic catalysed cross-coupling of aryl bromides with aryl triflates
    Ackerman, Laura K. G.
    Lovell, Matthew M.
    Weix, Daniel J.
    [J]. NATURE, 2015, 524 (7566) : 454 - +
  • [4] Natural products in drug discovery: advances and opportunities
    Atanasov, Atanas G.
    Zotchev, Sergey B.
    Dirsch, Verena M.
    Supuran, Claudiu T.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (03) : 200 - 216
  • [5] New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
    Baell, Jonathan B.
    Holloway, Georgina A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (07) : 2719 - 2740
  • [6] FBXW2 suppresses breast tumorigenesis by targeting AKT-Moesin-SKP2 axis
    Barik, Ganesh Kumar
    Sahay, Osheen
    Mukhopadhyay, Anindya
    Manne, Rajesh Kumar
    Islam, Sehbanul
    Roy, Anup
    Nath, Somsubhra
    Santra, Manas Kumar
    [J]. CELL DEATH & DISEASE, 2023, 14 (09)
  • [7] Bohm Hans-Joachim, 2004, Drug Discov Today Technol, V1, P217, DOI 10.1016/j.ddtec.2004.10.009
  • [8] Lessons learnt from assembling screening libraries for drug discovery for neglected diseases
    Brenk, Ruth
    Schipani, Alessandro
    James, Daniel
    Krasowski, Agata
    Gilbert, Ian Hugh
    Frearson, Julie
    Wyatt, Paul Graham
    [J]. CHEMMEDCHEM, 2008, 3 (03) : 435 - 444
  • [9] Antitumor Activity of Rutaecarpine in Human Colorectal Cancer Cells by Suppression of Wnt/?-Catenin Signaling
    Byun, Woong Sub
    Bae, Eun Seo
    Kim, Won Kyung
    Lee, Sang Kook
    [J]. JOURNAL OF NATURAL PRODUCTS, 2022, 85 (05): : 1407 - 1418
  • [10] Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma
    Carbone, Daniela
    De Franco, Michele
    Pecoraro, Camilla
    Bassani, Davide
    Pavan, Matteo
    Cascioferro, Stella
    Parrino, Barbara
    Cirrincione, Girolamo
    Dall'Acqua, Stefano
    Sut, Stefania
    Moro, Stefano
    Gandin, Valentina
    Diana, Patrizia
    [J]. MARINE DRUGS, 2023, 21 (05)